STOCK TITAN

[S-8] Longeveron Inc. Employee Benefit Plan Registration

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8
Rhea-AI Filing Summary

Longeveron Inc. (LGVN) has filed a Form S-8 to register an additional 4,000,000 shares of Class A Common Stock for issuance under its Third Amended and Restated 2021 Incentive Award Plan. The new shares, which were approved by shareholders on 13 June 2025, are in addition to 1,657,441 shares previously registered on three earlier S-8 filings (February 2021, June 2023 and July 2024, all share counts adjusted for a 26 March 2024 reverse split). Accordingly, the plan now has 5,657,441 registered shares available for equity-based compensation.

The filing is submitted under General Instruction E, thereby incorporating by reference all prior S-8 registration statements and the company’s periodic reports, including the Form 10-K for the fiscal year ended 31 Dec 2024 and all Forms 10-Q/8-K filed thereafter. Buchanan Ingersoll & Rooney PC rendered the legality opinion (its attorneys collectively own 2,000 LGVN shares), and Marcum LLP provided the auditor’s consent.

Key implications for investors:

  • Equity dilution risk: The 4 million newly registered shares will expand the incentive pool, increasing the potential supply of freely tradable shares as awards vest and are exercised.
  • Talent retention & alignment: A larger equity pool can strengthen management and employee retention incentives by allowing additional grants.
  • Shareholder oversight: Because the share increase required shareholder approval, governance processes were followed; LGVN remains a smaller reporting company and emerging growth company.

Longeveron Inc. (LGVN) ha presentato un modulo S-8 per registrare ulteriori 4.000.000 di azioni di Classe A Azioni Ordinarie da emettere secondo il suo Terzo Piano Incentivi 2021 Modificato e Ristabilito. Le nuove azioni, approvate dagli azionisti il 13 giugno 2025, si aggiungono alle 1.657.441 azioni già registrate in tre precedenti moduli S-8 (febbraio 2021, giugno 2023 e luglio 2024, tutti i conteggi azionari adeguati per uno split inverso del 26 marzo 2024). Di conseguenza, il piano dispone ora di 5.657.441 azioni registrate disponibili per la compensazione basata su azioni.

La presentazione è stata effettuata secondo l'Istruzione Generale E, incorporando per riferimento tutte le precedenti dichiarazioni di registrazione S-8 e i rapporti periodici della società, incluso il modulo 10-K per l'anno fiscale terminato il 31 dicembre 2024 e tutti i moduli 10-Q/8-K presentati successivamente. Buchanan Ingersoll & Rooney PC ha fornito il parere legale (i suoi avvocati possiedono collettivamente 2.000 azioni LGVN), mentre Marcum LLP ha fornito il consenso del revisore.

Implicazioni chiave per gli investitori:

  • Rischio di diluizione azionaria: Le 4 milioni di nuove azioni registrate aumenteranno il pool di incentivi, ampliando il potenziale numero di azioni liberamente negoziabili man mano che le assegnazioni maturano e vengono esercitate.
  • Fidelizzazione e allineamento dei talenti: Un pool azionario più ampio può rafforzare gli incentivi per la permanenza di dirigenti e dipendenti consentendo ulteriori concessioni.
  • Controllo degli azionisti: Poiché l'aumento delle azioni ha richiesto l'approvazione degli azionisti, sono stati rispettati i processi di governance; LGVN rimane una società di dimensioni minori con obblighi di comunicazione e una società emergente in crescita.

Longeveron Inc. (LGVN) ha presentado un Formulario S-8 para registrar 4.000.000 acciones adicionales de Clase A Acciones Comunes para su emisión bajo su Tercer Plan de Premios Incentivos 2021 Enmendado y Restablecido. Las nuevas acciones, aprobadas por los accionistas el 13 de junio de 2025, se suman a las 1.657.441 acciones previamente registradas en tres presentaciones S-8 anteriores (febrero 2021, junio 2023 y julio 2024, todos los conteos ajustados por una división inversa del 26 de marzo de 2024). Por lo tanto, el plan ahora cuenta con 5.657.441 acciones registradas disponibles para compensación basada en acciones.

La presentación se realizó bajo la Instrucción General E, incorporando por referencia todas las declaraciones de registro S-8 anteriores y los informes periódicos de la compañía, incluyendo el Formulario 10-K para el año fiscal terminado el 31 de diciembre de 2024 y todos los Formularios 10-Q/8-K presentados posteriormente. Buchanan Ingersoll & Rooney PC emitió la opinión legal (sus abogados poseen colectivamente 2.000 acciones LGVN), y Marcum LLP proporcionó el consentimiento del auditor.

Implicaciones clave para los inversores:

  • Riesgo de dilución accionaria: Las 4 millones de nuevas acciones registradas ampliarán el fondo de incentivos, aumentando la oferta potencial de acciones libremente negociables a medida que las concesiones se consoliden y ejerzan.
  • Retención y alineación del talento: Un fondo de acciones más grande puede fortalecer los incentivos para la retención de gerentes y empleados al permitir concesiones adicionales.
  • Supervisión de los accionistas: Debido a que el aumento de acciones requirió aprobación de los accionistas, se siguieron los procesos de gobernanza; LGVN sigue siendo una compañía pequeña que reporta y una compañía emergente en crecimiento.

Longeveron Inc.(LGVN)은 제3차 수정 및 재정립된 2021년 인센티브 보상 계획에 따라 추가로 4,000,000주의 클래스 A 보통주를 등록하기 위해 Form S-8을 제출했습니다. 이 새로운 주식은 2025년 6월 13일 주주들의 승인을 받았으며, 이전에 3차례의 S-8 제출(2021년 2월, 2023년 6월, 2024년 7월, 모두 2024년 3월 26일 역병합 조정 후 주식 수 기준)에 등록된 1,657,441주에 추가된 것입니다. 따라서 현재 이 계획은 총 5,657,441주의 등록 주식을 주식 기반 보상에 사용할 수 있습니다.

이 제출은 일반 지침 E에 따라 이루어졌으며, 이전 모든 S-8 등록 명세서와 회사의 정기 보고서, 2024년 12월 31일 종료된 회계연도에 대한 Form 10-K 및 이후 제출된 모든 Form 10-Q/8-K를 참고 문서로 포함합니다. Buchanan Ingersoll & Rooney PC가 법률 의견을 제공했으며(이들 변호사들은 총 2,000주의 LGVN 주식을 보유), Marcum LLP가 감사인의 동의를 제공했습니다.

투자자에게 중요한 시사점:

  • 주식 희석 위험: 새로 등록된 400만 주는 인센티브 풀을 확장하여 보상이 확정되고 행사될 때 자유롭게 거래 가능한 주식 공급을 증가시킵니다.
  • 인재 유지 및 정렬: 더 큰 주식 풀은 추가 부여를 허용하여 경영진과 직원의 유지 인센티브를 강화할 수 있습니다.
  • 주주 감독: 주식 증가가 주주 승인을 필요로 했기 때문에 거버넌스 절차가 준수되었으며, LGVN은 여전히 소규모 보고 회사이자 신흥 성장 회사입니다.

Longeveron Inc. (LGVN) a déposé un formulaire S-8 pour enregistrer 4 000 000 d’actions supplémentaires de Classe A Actions Ordinaires à émettre dans le cadre de son Troisième Plan d’Attribution d’Incentives 2021 Amendé et Restitué. Les nouvelles actions, approuvées par les actionnaires le 13 juin 2025, s’ajoutent aux 1 657 441 actions précédemment enregistrées lors de trois dépôts S-8 antérieurs (février 2021, juin 2023 et juillet 2024, tous les décomptes ajustés suite à une division inversée du 26 mars 2024). Par conséquent, le plan dispose désormais de 5 657 441 actions enregistrées disponibles pour la rémunération en actions.

Le dépôt a été effectué conformément à l’Instruction Générale E, incorporant par référence toutes les déclarations d’enregistrement S-8 antérieures ainsi que les rapports périodiques de la société, y compris le formulaire 10-K pour l’exercice clos le 31 décembre 2024 et tous les formulaires 10-Q/8-K déposés par la suite. Buchanan Ingersoll & Rooney PC a rendu son avis légal (ses avocats détiennent collectivement 2 000 actions LGVN), et Marcum LLP a donné son consentement d’auditeur.

Principales implications pour les investisseurs :

  • Risque de dilution des actions : Les 4 millions de nouvelles actions enregistrées vont augmenter le pool d’incitations, accroissant l’offre potentielle d’actions librement négociables à mesure que les attributions arrivent à échéance et sont exercées.
  • Rétention et alignement des talents : Un pool d’actions plus important peut renforcer les incitations à la rétention des cadres et des employés en permettant des attributions supplémentaires.
  • Surveillance des actionnaires : Comme l’augmentation des actions a nécessité l’approbation des actionnaires, les processus de gouvernance ont été respectés ; LGVN reste une petite société assujettie à l’obligation de rapport et une société émergente en croissance.

Longeveron Inc. (LGVN) hat ein Formular S-8 eingereicht, um weitere 4.000.000 Aktien der Klasse A Stammaktien zur Ausgabe im Rahmen seines Dritten Geänderten und Neuformulierten Incentive Award Plans 2021 zu registrieren. Die neuen Aktien, die am 13. Juni 2025 von den Aktionären genehmigt wurden, kommen zusätzlich zu 1.657.441 Aktien, die zuvor in drei früheren S-8-Anmeldungen registriert wurden (Februar 2021, Juni 2023 und Juli 2024, alle Stückzahlen angepasst für einen Reverse Split am 26. März 2024). Dementsprechend stehen dem Plan nun 5.657.441 registrierte Aktien für aktienbasierte Vergütungen zur Verfügung.

Die Einreichung erfolgte gemäß Allgemeiner Anweisung E, wodurch alle vorherigen S-8-Registrierungserklärungen und die periodischen Berichte des Unternehmens, einschließlich des Formulars 10-K für das Geschäftsjahr zum 31. Dezember 2024 sowie aller danach eingereichten Formulare 10-Q/8-K, durch Verweis einbezogen werden. Buchanan Ingersoll & Rooney PC gab die Rechtsmeinung ab (deren Anwälte besitzen zusammen 2.000 LGVN-Aktien), und Marcum LLP erteilte die Zustimmung des Wirtschaftsprüfers.

Wichtige Auswirkungen für Investoren:

  • Aktienverwässerungsrisiko: Die 4 Millionen neu registrierten Aktien erweitern den Anreizpool und erhöhen das potenzielle Angebot an frei handelbaren Aktien, wenn Auszeichnungen fällig werden und ausgeübt werden.
  • Talentbindung & Ausrichtung: Ein größerer Aktienpool kann die Anreize zur Bindung von Management und Mitarbeitern stärken, indem zusätzliche Zuteilungen ermöglicht werden.
  • Aktionärskontrolle: Da die Erhöhung der Aktien die Zustimmung der Aktionäre erforderte, wurden Governance-Prozesse eingehalten; LGVN bleibt ein kleiner berichtspflichtiger Konzern und ein aufstrebendes Wachstumsunternehmen.
Positive
  • Shareholder-approved increase demonstrates adherence to governance norms and investor oversight.
  • Expanded equity pool may improve talent retention and alignment of management with shareholder interests.
Negative
  • Potential dilution: Registration of 4,000,000 additional shares increases the supply of stock that could enter the market.
  • No immediate cash inflow: Unlike a primary offering, the S-8 does not raise capital, limiting direct financial benefit.

Insights

TL;DR – Routine S-8 adds 4 M shares; modest dilution, neutral overall.

The filing is an administrative move to refresh LGVN’s employee equity plan. Adding 4 million shares materially enlarges the incentive pool but does not itself raise cash or alter operations, so the immediate market impact should be limited. Potential dilution depends on actual issuance and the company’s total shares outstanding (not disclosed here). Shareholder approval suggests governance discipline. Overall, the action is common for emerging growth companies seeking to retain talent; I view the net effect as neutral to slightly dilutive.

TL;DR – Shareholder-approved share increase signals sound process; dilution caveat remains.

From a governance standpoint, LGVN followed best practice by securing shareholder consent before tripling its plan reserve. Incorporating prior filings under Instruction E streamlines disclosure and lowers filing costs. The indemnification and D&O protections disclosed are standard for Delaware corporations. While larger equity pools can erode existing holders’ stake over time, transparent approval mitigates governance risk. Overall, the action is orderly and not materially impactful beyond dilution considerations.

Longeveron Inc. (LGVN) ha presentato un modulo S-8 per registrare ulteriori 4.000.000 di azioni di Classe A Azioni Ordinarie da emettere secondo il suo Terzo Piano Incentivi 2021 Modificato e Ristabilito. Le nuove azioni, approvate dagli azionisti il 13 giugno 2025, si aggiungono alle 1.657.441 azioni già registrate in tre precedenti moduli S-8 (febbraio 2021, giugno 2023 e luglio 2024, tutti i conteggi azionari adeguati per uno split inverso del 26 marzo 2024). Di conseguenza, il piano dispone ora di 5.657.441 azioni registrate disponibili per la compensazione basata su azioni.

La presentazione è stata effettuata secondo l'Istruzione Generale E, incorporando per riferimento tutte le precedenti dichiarazioni di registrazione S-8 e i rapporti periodici della società, incluso il modulo 10-K per l'anno fiscale terminato il 31 dicembre 2024 e tutti i moduli 10-Q/8-K presentati successivamente. Buchanan Ingersoll & Rooney PC ha fornito il parere legale (i suoi avvocati possiedono collettivamente 2.000 azioni LGVN), mentre Marcum LLP ha fornito il consenso del revisore.

Implicazioni chiave per gli investitori:

  • Rischio di diluizione azionaria: Le 4 milioni di nuove azioni registrate aumenteranno il pool di incentivi, ampliando il potenziale numero di azioni liberamente negoziabili man mano che le assegnazioni maturano e vengono esercitate.
  • Fidelizzazione e allineamento dei talenti: Un pool azionario più ampio può rafforzare gli incentivi per la permanenza di dirigenti e dipendenti consentendo ulteriori concessioni.
  • Controllo degli azionisti: Poiché l'aumento delle azioni ha richiesto l'approvazione degli azionisti, sono stati rispettati i processi di governance; LGVN rimane una società di dimensioni minori con obblighi di comunicazione e una società emergente in crescita.

Longeveron Inc. (LGVN) ha presentado un Formulario S-8 para registrar 4.000.000 acciones adicionales de Clase A Acciones Comunes para su emisión bajo su Tercer Plan de Premios Incentivos 2021 Enmendado y Restablecido. Las nuevas acciones, aprobadas por los accionistas el 13 de junio de 2025, se suman a las 1.657.441 acciones previamente registradas en tres presentaciones S-8 anteriores (febrero 2021, junio 2023 y julio 2024, todos los conteos ajustados por una división inversa del 26 de marzo de 2024). Por lo tanto, el plan ahora cuenta con 5.657.441 acciones registradas disponibles para compensación basada en acciones.

La presentación se realizó bajo la Instrucción General E, incorporando por referencia todas las declaraciones de registro S-8 anteriores y los informes periódicos de la compañía, incluyendo el Formulario 10-K para el año fiscal terminado el 31 de diciembre de 2024 y todos los Formularios 10-Q/8-K presentados posteriormente. Buchanan Ingersoll & Rooney PC emitió la opinión legal (sus abogados poseen colectivamente 2.000 acciones LGVN), y Marcum LLP proporcionó el consentimiento del auditor.

Implicaciones clave para los inversores:

  • Riesgo de dilución accionaria: Las 4 millones de nuevas acciones registradas ampliarán el fondo de incentivos, aumentando la oferta potencial de acciones libremente negociables a medida que las concesiones se consoliden y ejerzan.
  • Retención y alineación del talento: Un fondo de acciones más grande puede fortalecer los incentivos para la retención de gerentes y empleados al permitir concesiones adicionales.
  • Supervisión de los accionistas: Debido a que el aumento de acciones requirió aprobación de los accionistas, se siguieron los procesos de gobernanza; LGVN sigue siendo una compañía pequeña que reporta y una compañía emergente en crecimiento.

Longeveron Inc.(LGVN)은 제3차 수정 및 재정립된 2021년 인센티브 보상 계획에 따라 추가로 4,000,000주의 클래스 A 보통주를 등록하기 위해 Form S-8을 제출했습니다. 이 새로운 주식은 2025년 6월 13일 주주들의 승인을 받았으며, 이전에 3차례의 S-8 제출(2021년 2월, 2023년 6월, 2024년 7월, 모두 2024년 3월 26일 역병합 조정 후 주식 수 기준)에 등록된 1,657,441주에 추가된 것입니다. 따라서 현재 이 계획은 총 5,657,441주의 등록 주식을 주식 기반 보상에 사용할 수 있습니다.

이 제출은 일반 지침 E에 따라 이루어졌으며, 이전 모든 S-8 등록 명세서와 회사의 정기 보고서, 2024년 12월 31일 종료된 회계연도에 대한 Form 10-K 및 이후 제출된 모든 Form 10-Q/8-K를 참고 문서로 포함합니다. Buchanan Ingersoll & Rooney PC가 법률 의견을 제공했으며(이들 변호사들은 총 2,000주의 LGVN 주식을 보유), Marcum LLP가 감사인의 동의를 제공했습니다.

투자자에게 중요한 시사점:

  • 주식 희석 위험: 새로 등록된 400만 주는 인센티브 풀을 확장하여 보상이 확정되고 행사될 때 자유롭게 거래 가능한 주식 공급을 증가시킵니다.
  • 인재 유지 및 정렬: 더 큰 주식 풀은 추가 부여를 허용하여 경영진과 직원의 유지 인센티브를 강화할 수 있습니다.
  • 주주 감독: 주식 증가가 주주 승인을 필요로 했기 때문에 거버넌스 절차가 준수되었으며, LGVN은 여전히 소규모 보고 회사이자 신흥 성장 회사입니다.

Longeveron Inc. (LGVN) a déposé un formulaire S-8 pour enregistrer 4 000 000 d’actions supplémentaires de Classe A Actions Ordinaires à émettre dans le cadre de son Troisième Plan d’Attribution d’Incentives 2021 Amendé et Restitué. Les nouvelles actions, approuvées par les actionnaires le 13 juin 2025, s’ajoutent aux 1 657 441 actions précédemment enregistrées lors de trois dépôts S-8 antérieurs (février 2021, juin 2023 et juillet 2024, tous les décomptes ajustés suite à une division inversée du 26 mars 2024). Par conséquent, le plan dispose désormais de 5 657 441 actions enregistrées disponibles pour la rémunération en actions.

Le dépôt a été effectué conformément à l’Instruction Générale E, incorporant par référence toutes les déclarations d’enregistrement S-8 antérieures ainsi que les rapports périodiques de la société, y compris le formulaire 10-K pour l’exercice clos le 31 décembre 2024 et tous les formulaires 10-Q/8-K déposés par la suite. Buchanan Ingersoll & Rooney PC a rendu son avis légal (ses avocats détiennent collectivement 2 000 actions LGVN), et Marcum LLP a donné son consentement d’auditeur.

Principales implications pour les investisseurs :

  • Risque de dilution des actions : Les 4 millions de nouvelles actions enregistrées vont augmenter le pool d’incitations, accroissant l’offre potentielle d’actions librement négociables à mesure que les attributions arrivent à échéance et sont exercées.
  • Rétention et alignement des talents : Un pool d’actions plus important peut renforcer les incitations à la rétention des cadres et des employés en permettant des attributions supplémentaires.
  • Surveillance des actionnaires : Comme l’augmentation des actions a nécessité l’approbation des actionnaires, les processus de gouvernance ont été respectés ; LGVN reste une petite société assujettie à l’obligation de rapport et une société émergente en croissance.

Longeveron Inc. (LGVN) hat ein Formular S-8 eingereicht, um weitere 4.000.000 Aktien der Klasse A Stammaktien zur Ausgabe im Rahmen seines Dritten Geänderten und Neuformulierten Incentive Award Plans 2021 zu registrieren. Die neuen Aktien, die am 13. Juni 2025 von den Aktionären genehmigt wurden, kommen zusätzlich zu 1.657.441 Aktien, die zuvor in drei früheren S-8-Anmeldungen registriert wurden (Februar 2021, Juni 2023 und Juli 2024, alle Stückzahlen angepasst für einen Reverse Split am 26. März 2024). Dementsprechend stehen dem Plan nun 5.657.441 registrierte Aktien für aktienbasierte Vergütungen zur Verfügung.

Die Einreichung erfolgte gemäß Allgemeiner Anweisung E, wodurch alle vorherigen S-8-Registrierungserklärungen und die periodischen Berichte des Unternehmens, einschließlich des Formulars 10-K für das Geschäftsjahr zum 31. Dezember 2024 sowie aller danach eingereichten Formulare 10-Q/8-K, durch Verweis einbezogen werden. Buchanan Ingersoll & Rooney PC gab die Rechtsmeinung ab (deren Anwälte besitzen zusammen 2.000 LGVN-Aktien), und Marcum LLP erteilte die Zustimmung des Wirtschaftsprüfers.

Wichtige Auswirkungen für Investoren:

  • Aktienverwässerungsrisiko: Die 4 Millionen neu registrierten Aktien erweitern den Anreizpool und erhöhen das potenzielle Angebot an frei handelbaren Aktien, wenn Auszeichnungen fällig werden und ausgeübt werden.
  • Talentbindung & Ausrichtung: Ein größerer Aktienpool kann die Anreize zur Bindung von Management und Mitarbeitern stärken, indem zusätzliche Zuteilungen ermöglicht werden.
  • Aktionärskontrolle: Da die Erhöhung der Aktien die Zustimmung der Aktionäre erforderte, wurden Governance-Prozesse eingehalten; LGVN bleibt ein kleiner berichtspflichtiger Konzern und ein aufstrebendes Wachstumsunternehmen.

As filed with the Securities and Exchange Commission on June 20, 2025

Registration No. 333-                

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

LONGEVERON INC.

(Exact name of registrant as specified in its charter)

 

Delaware   47-2174146

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. employer

identification number)

 

1951 NW 7th Avenue, Suite 520

Miami, Florida

  33136
(Address of Principal Executive Offices)   (Zip Code)

 

Third Amended and Restated Longeveron Inc. 2021 Incentive Award Plan

(Full title of the Plan)

 

Wa’el Hashad

Chief Executive Officer

Longeveron Inc.

1951 NW 7th Ave., Suite 520

Miami, FL 33136

(Name and address of agent for service)

 

(305) 909-0840

(Telephone number, including area code, of agent for service)

 

Copies to:

 

Jennifer R. Minter, Esq.
Stanley A. Marciniak III, Esq.

Buchanan Ingersoll & Rooney PC

Union Trust Building

501 Grant Street, Suite 200

Pittsburgh, PA 15219

(412) 562-8800

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

 

 

EXPLANATORY NOTE

 

Longeveron Inc. (referred to as the “Registrant,” “the Company,” “we,” “us” or “our” unless specified otherwise) is filing this registration statement on Form S-8 (the “Registration Statement”) for the purpose of registering an additional 4,000,000 shares of our Class A Common Stock, par value $0.001 per share (“Class A Common Stock”), for issuance under the Third Amended and Restated Longeveron Inc. 2021 Incentive Award Plan (the “Plan”). The increase in the number of shares authorized for issuance under the Plan was approved by our stockholders at our annual meeting held on June 13, 2025. The 4,000,000 shares of Class A Common Stock being registered pursuant to this Registration Statement are in addition to the following (as to each, after adjusting for the reverse stock split effective as of March 26, 2024): (i) the 207,441 shares of Class A Common Stock under the Plan currently registered on our Registration Statement on Form S-8 filed on February 16, 2021, file number 333-253141 (the “2021 Registration Statement”), (ii) the 150,000 shares of Class A Common Stock under the Plan currently registered on our Registration Statement on Form S-8 filed on June 26, 2023, file number 333-272938 (the “2023 Registration Statement”) and (iii) the 1,300,000 shares of Class A Common Stock under the Plan currently registered on our Registration Statement on Form S-8 filed on July 10, 2024, file number 333-280747 (the “2024 Registration Statement,” and collectively with the 2021 Registration Statement and the 2023 Registration Statement, the “Prior Registration Statements”). This Registration Statement relates to the same class of securities to which the Prior Registration Statements relate and is submitted pursuant to General Instruction E to Form S-8. Pursuant to General Instruction E, this Registration Statement incorporates by reference the contents of the Prior Registration Statements.

 

 

 

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

In addition to the Prior Registration Statements, this Registration Statement incorporates by reference the documents listed below, which were previously filed by us with the Securities and Exchange Commission (the “SEC”) (other than portions of these documents that are deemed furnished, rather than filed under applicable SEC rules and exhibits furnished in connection with such items):

 

  (a) Our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 28, 2025;
     
  (b) All other reports filed by us pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), since December 31, 2024 (in each case, except for the information furnished under Items 2.02 or 7.01 in any Current Report on Form 8-K); and
     
  (c) The description of our Class A Common Stock set forth in the Registration Statement on Form 8-A (File No. 001-40060), filed by the Registrant with the SEC under Section 12(b) of the Exchange Act on February 11, 2021, including Exhibit 4.2 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on February 28, 2025 and any other amendments or reports filed for the purpose of updating such description.

 

In addition, all documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such documents, except as to specific sections of such statements as set forth therein. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement contained herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

Under no circumstances shall any information furnished under Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

 

Item 5. Interests of Named Experts and Counsel.

 

The validity of the securities registered hereby has been passed upon for the Company by Buchanan Ingersoll & Rooney PC (“Buchanan”), Pittsburgh, Pennsylvania. Certain attorneys affiliated with Buchanan beneficially own an aggregate of 2,000 shares of our Class A Common Stock.

 

Item 6. Indemnification of Directors and Officers.

 

Section 102 of the Delaware General Corporation Law (“DGCL”) permits a corporation to eliminate the personal liability of directors and officers of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director or officer, except where the director or officer breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, or obtained an improper personal benefit, or in the case of directors authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law. Our certificate of incorporation, as amended (the “Certificate of Incorporation”) provides that no director shall be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty.

 

II-1

 

 

Section 145 of the DGCL provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation, or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.

 

Our Certificate of Incorporation provides that we will indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an “Indemnitee”), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. Our Certificate of Incorporation provides that we will indemnify any Indemnitee who was or is a party to an action or suit by or in the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys’ fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys’ fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances.

 

We have entered into indemnification agreements with each of our directors and officers. These indemnification agreements may require us, among other things, to indemnify our directors and officers for some expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as one of our directors or officers, or any of our subsidiaries or any other company or enterprise to which the person provides services at our request.

 

We maintain a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers.

 

II-2

 

 

Item 8. Exhibits.

 

Exhibit Number   Exhibit Description   Method of Filing
         
4.1   Certificate of Incorporation of Longeveron Inc.   Incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-8 filed on February 16, 2021
4.2   Certificate of Amendment to Certificate of Incorporation of Longeveron Inc.   Incorporated by reference to Exhibit 3.1(a) to the Registrant’s Current Report on Form 8-K filed March 19, 2024
4.3   Bylaws of Longeveron Inc.   Incorporated by reference to Exhibit 4.2 to the Registrant’s Registration Statement on Form S-8 filed on February 16, 2021
4.4   Specimen Class A Common Stock Certificate evidencing the shares of Class A Common Stock   Incorporated by reference to Exhibit 4.1 on Registrant’s Registration Statement No. 333-252234 filed February 3, 2021
5.1   Opinion of Buchanan Ingersoll & Rooney PC   Filed herewith
23.1   Consent of Marcum LLP, Independent Registered Public Accounting Firm   Filed herewith
23.2   Consent of Buchanan Ingersoll & Rooney PC (included in Exhibit 5.1 hereto)   Included in its opinion filed as Exhibit 5.1 hereto
24.1   Power of Attorney   Included on Signature Page
99.1   Third Amended and Restated Longeveron Inc. 2021 Incentive Award Plan   Filed herewith
107   Filing Fee Table   Filed herewith

 

II-3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, Florida, on June 20, 2025.

 

  LONGEVERON INC.
   
  By: /s/ Wa’el Hashad
    Wa’el Hashad
    Chief Executive Officer

 

POWER OF ATTORNEY

 

Each person whose signature appears below constitutes and appoints Wa’el Hashad, Lisa Locklear and Paul Lehr and each of them singly, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement on Form S-8 and any and all amendments (including post-effective amendments) thereto of Longeveron Inc. and to file the same, with all exhibits thereto and all other documents in connection therewith, with the SEC, granting unto each said attorney-in-fact and agents full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or either of them or their, his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities held on the dates indicated.

 

Signature   Title   Date
         
/s/ Wa’el Hashad   Chief Executive Officer and Director   June 20, 2025
Wa’el Hashad   (principal executive officer)    
         
/s/ Lisa A. Locklear   Chief Financial Officer   June 20, 2025
Lisa A. Locklear   (principal financial officer and principal accounting officer)    
         
/s/ Joshua M. Hare        
Joshua M. Hare   Chairman of the Board and Chief Science Officer   June 20, 2025
         
/s/ Khoso Baluch        
Khoso Baluch   Director   June 20, 2025
         
/s/ Roger Hajjar        
Roger Hajjar   Director   June 20, 2025
         
/s/ Richard Kender        
Richard Kender   Director   June 20, 2025
         
/s/ Neha Motwani        
Neha Motwani   Director   June 20, 2025
         
/s/ Rock Soffer        
Rock Soffer   Director   June 20, 2025
         
/s/ Ursula Ungaro        
Ursula Ungaro   Director    June 20, 2025
         

 

 

II-4

 

FAQ

Why did Longeveron (LGVN) file a new Form S-8?

To register 4,000,000 additional Class A shares for issuance under its 2021 Incentive Award Plan.

How many total shares are now registered under LGVN’s 2021 Incentive Award Plan?

Including prior registrations, the plan now covers 5,657,441 shares of Class A Common Stock.

When did shareholders approve the share increase for the incentive plan?

Shareholders approved the increase at the 13 June 2025 annual meeting.

Will the Form S-8 directly affect LGVN’s cash position?

No. A Form S-8 registers shares for employee compensation and does not generate immediate proceeds.

Who provided the legal opinion for the registration statement?

Buchanan Ingersoll & Rooney PC issued the legality opinion; some of its attorneys own 2,000 LGVN shares.

Is Longeveron still classified as an emerging growth company?

Yes. The filing designates LGVN as a non-accelerated filer, smaller reporting company, and emerging growth company.
Longeveron Inc

NASDAQ:LGVN

LGVN Rankings

LGVN Latest News

LGVN Latest SEC Filings

LGVN Stock Data

13.05M
11.86M
12.3%
8.59%
3.97%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIAMI